We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Novel Balance Gene Identified

By Biotechdaily staff writers
Posted on 02 Apr 2003
Researchers have identified a gene, which they call otopetrin 1, that plays a key role in the embryonic development of otoconia, biominerals within the utricle and saccule of the inner ear that are critical for the perception of gravity and linear acceleration. More...
Their findings were published March 24, 2003, in the online edition of Human Molecular Genetics.

Previous research has shown that otoconia are only produced during development, and that they progressively degrade throughout life. How otoconia develop and whether it may be possible to stimulate the production or regeneration of these particles are not well understood.

In the current study, researchers from Washington University (St. Louis, MO, USA; www.wustl.edu) located the same mutation in two different lines of mice, tilted (tlt) and mergulhador (mlh), which were known to have balance problems. Both strains lack otoconia but have normal sensory hair cells. The researchers named the mutated gene otopetrin 1.

"It is possible that this is one of the genes that shuts down after development,” explained senior author Dr. David Ornitz, professor of molecular biology and pharmacology at the Washington University School of Medicine. "It also is possible that it is involved in a variety of vestibular disorders. If we can find a way to reactivate this gene, we may be able to help otoconia regenerate and thereby treat or prevent balance disorders.”



Related Links:
Washington University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
All-in-One Molecular System
AIO M160
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.